Chemoinformaics analysis of alpha-l-arabinofuranosyl glucopyranoside
Molecular Weight | 312.271 | nRot | 4 |
Heavy Atom Molecular Weight | 292.111 | nRig | 11 |
Exact Molecular Weight | 312.106 | nRing | 2 |
Solubility: LogS | 0.004 | nHRing | 2 |
Solubility: LogP | -2.989 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 11 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
nHA | 10 | APOL | 39.7259 |
nHD | 7 | BPOL | 25.2721 |
QED | 0.267 |
Synth | 4.064 |
Natural Product Likeliness | 1.729 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0.7 |
HIA | 0.981 |
CACO-2 | -5.799 |
MDCK | 0.000501048 |
BBB | 0.418 |
PPB | 0.146602 |
VDSS | 0.295 |
FU | 0.70077 |
CYP1A2-inh | 0.002 |
CYP1A2-sub | 0.021 |
CYP2c19-inh | 0.005 |
CYP2c19-sub | 0.075 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.081 |
CYP2d6-inh | 0 |
CYP2d6-sub | 0.104 |
CYP3a4-inh | 0.003 |
CYP3a4-sub | 0.003 |
CL | 1.298 |
T12 | 0.624 |
hERG | 0.032 |
Ames | 0.223 |
ROA | 0.142 |
SkinSen | 0.021 |
Carcinogencity | 0.022 |
EI | 0.011 |
Respiratory | 0.012 |
NR-Aromatase | 0.006 |
Antiviral | Yes |
Prediction | 0.746165 |